Skip to main navigation Skip to search Skip to main content

A randomised, double-blind, placebo-controlled, study to evaluqate the efficacty and safety of sate-547 injection in the treatment of subjects with refractory status epilepticus who have failed standard treatment

Project: Research

Project Details

StatusFinished
Effective start/end date01/7/16 → 01/6/20

Funding

  • Sage Therapeutics Incorporated: $32,407.50